AB
Annovis Bio Inc
🇺🇸XNYS.ANVSUnited StatesHealthcare
$1.12USDdown -0.02 (-1.75%)OpenEnd of day3:31 PM
Price$1.12-0.02 (-1.75%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US03615A1088
- CUSIP
- 03615A108
Company
- Employees
- 7
- Headquarters
- Malvern, United States
- Website
- https://www.annovisbio.com
- CEO
- Dr. Maria L. Maccecchini Ph.D.
Market
- Shares outstanding
- 42.6M
- Market cap
- $47.72M
Highlights
- Market cap
- $47.72M
- EPS LTM
- -$1.32
- P/E LTM
- -1.41
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$49.52M-63.66%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$43.34M-75.52%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.